SEARCHCROSS-SECTIONALinternal medicine, epidemiology

cross-sectional·internal medicine, epidemiology, public health, nutrition·PMC10061647

Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates

American Journal of Men's Health · 8 authors, 13 centres

AI SUMMARY

FIDELITY 100%

This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.

AGENT 01 · STRUCTURED SUMMARY

TRACE TO SOURCE

“

TL;DR

This cross-sectional survey of 1,101 male university participants in the UAE found that 39.3% reported using sexual enhancement supplements, with use more prevalent among older individuals and those with chronic conditions like diabetes or hypertension.

Full summary

467 CHARS

This cross-sectional study used a self-administered online survey to assess the prevalence, adverse effects, and risk awareness of sexual enhancement supplement (SES) use among 1,101 male participants at Ajman University in the UAE. The study found that 39.3% of participants used SES products, with 31.6% of users reporting adverse effects. The authors conclude that SES use is common in this population and recommend risk awareness programs and regulatory guidance.

STUDY TYPE

cross-sectional

SPECIALTY

internal medicine

SUMMARISED BY

AI pipeline

FIDELITY CHECK

100% · A

ORIGINAL PAPER

PMC10061647

Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates

American Journal of Men's Health

READ THE FULL PAPER

ABSTRACT

Sexual enhancement supplements (SESs) that have illegal additions of pharmaceuticals or analogues pose a significant health risk, particularly with long-term usage. When supplements are adulterated with phosphodiesterase type 5 (PDE-5) inhibitors, dosages can vary widely and there may be an increase in adverse effects and drug–drug interactions which cannot be avoided. Consequently, there is a need to evaluate the public risk awareness toward SES and the associated adverse events as well as explore significant factors associated with knowledge and risk awareness. A cross-sectional community-based study was conducted among University male students and staff at Ajman University, United Arab Emirates (UAE), using a self-administered survey via a web-based electronic link to explore key issues. A total of 1,101 male subjects participated in the study and completed the questionnaire. Four hundred and thirty-three(39.3%) (95% confidence interval [CI]: 33.2–44.5) participants reported using SES products. Of these, 137 (31.6%) [95% CI: 28.6–37.2] experienced adverse effects from SES product use. SES use was more prevalent among participants aged 60 to 69 years (odds ratio [OR]: 2.94; 95% CI: 1.63–5.28), diabetic patients (OR: 2.61; 95% CI: 1.75–3.90), hypertension patients (OR: 2.12; 95% CI: 1.45–3.1), and those overweight or obese (OR: 1.84; 95% CI: 1.44–2.35). This study indicates that SES is a popular practice among the UAE university staff and students. However, there is a need to implement risk awareness programs to raise public awareness regarding SES use and safety. Regulatory bodies are encouraged to provide additional advice on the proper use and possible risks of consuming SES.

CITATION EXPORT

Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan et al.. Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates. American Journal of Men's Health. (2023). https://doi.org/10.1177/15579883231158531

AUTHORS

8 · 13 CENTRES

Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Balsam Qubais Saeed, Brian Godman, Amanj Kurdi, Samer H. Zyoud, Baharudin Ibrahim

1Health and Safety Department, Dubai Municipality, Dubai, UAE
2Pharmacy Department, Emirates Health Services, Dubai, UAE
3Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE
4Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, UAE
5Clinical Science Department, College of Medicine, University of Sharjah, Sharjah, UAE
6Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
7Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako-Makgatho Health Sciences University, Pretoria, South Africa
8Center of Research and Strategic Studies, Lebanese French University, Erbil, Kurdistan Region Government, Iraq
9Department of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region Government, Iraq
10Department of Mathematics and Sciences, Ajman University, Ajman, UAE
11Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, Ajman, UAE
12Nonlinear Dynamics Research Center (NDRC), Ajman University, Ajman, UAE
13Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia